SCHEMBL7895997

SCHEMBL7895997

Cc1ccc2nc(F)cn2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.41
AHR P35869 4/20 0.37
ALDH1A3 P47895 1/20 0.37
RBP4 P02753 1/20 0.36
KDM4E B2RXH2 5/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
SMN1; SMN2 Q16637 5/20 0.35
ALDH1A1 P00352 4/20 0.35
MITF O75030 1/20 0.35
KDM5A P29375 1/20 0.35
KDM5C P41229 1/20 0.35
PAX8 Q06710 1/20 0.35
COMT P21964 1/20 0.35
CYP11B2 P19099 4/20 0.34
CYP11B1 P15538 3/20 0.34
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3921056 0.81 DYRK1A (0.58) DYRK1AAHRRBP4KDM4EKMT2A
SCHEMBL13750601 0.78 DYRK1A (0.41) DYRK1AAHRALDH1A3KDM4EKMT2A
SCHEMBL26373829 0.78 DYRK1A (0.42) DYRK1AAHRRBP4KDM4EKMT2A
SCHEMBL13750599 0.77 F2RL3 (0.49) DYRK1AAHRRBP4NPC1RAB9A
SCHEMBL25104909 0.76 DYRK1A (0.41) DYRK1AAHRRBP4KDM4EKMT2A
SCHEMBL7889606 0.76 DYRK1A (0.41) DYRK1AAHRRBP4KDM4EKMT2A
SCHEMBL3086869 0.76 KDM4E (0.44) DYRK1AAHRRBP4KDM4EKMT2A
SCHEMBL12673757 0.76 DYRK1A (0.41) DYRK1AAHRRBP4KDM4EKMT2A
SCHEMBL17232819 0.76 DYRK1A (0.53) DYRK1AAHRALDH1A3KDM4ENPC1
SCHEMBL2067920 0.76 PDE10A (0.34) DYRK1AAHRALDH1A3KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150322069-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS FMR LLC 2015-11-12 US disclosed
US-8946222-B2 Phenoxymethyl heterocyclic compounds FORUM PHARMACEUTICALS INC. (US) 2015-02-03 US disclosed
US-20130143888-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS ENVIVO PHAMACEUTICALS, INC. (US) 2013-06-06 US disclosed
WO-2010128995-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS ENVIVO PHARMACEUTICALS, INC. (US) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150322069-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS PDE3A, PDE2A, PDE5A DYRK1A 4075/4885AHR 2665/4885ALDH1A3 926/4885
US-20130143888-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS PDE3A, PDE2A, PDE5A DYRK1A 4075/4885AHR 2665/4885ALDH1A3 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.